Physician

Purvi Gada, MBBS

According to 2025 Medicare claims, Purvi Gada, MBBS (NPI: 1639209224) practices medical oncology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Carver, MN. This provider's primary affiliated billing organization is MINNESOTA ONCOLOGY HEMATOLOGY, PA (NPI: 1528035995; TIN: 411793418) and primary practice location at 55318-2680. Gada is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483) and Essentia Health ACO, Inc. (ACO ID: A5617), participating under the MSSP model.

Gada's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 246 traditional Medicare patients, billed 132,485 HCPCS/CPT codes, and received $2,108,389 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 851 prescription claims across 203 beneficiaries totaling $1,631,482 in drug costs, led by Cabometyx (Cabozantinib S-Malate). 2021 DME data shows 13 claims. Open Payments data shows 21 records totaling $15,847. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $143,237 to $2,108,389. Similarly, Part D prescription costs have risen steadily, from $25,594 to $1,631,482. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.1M2015 Medicare payment: $143,237 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $260,745 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $656,217 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $540,618 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $872,056 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,220,254 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,912,280 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,746,587 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,550,068 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,108,389 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153010,202$143,237
20167217,644$260,745
20178838,651$656,217
20189239,788$540,618
201916457,259$872,056
202025564,816$1,220,254
202122096,289$1,912,280
202223093,267$1,746,587
202322692,732$1,550,068
2024246132,485$2,108,389

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$959K$1.9M2015 Drug cost: $25,594 (USD; Tot_Drug_Cst)2016 Drug cost: $190,922 (USD; Tot_Drug_Cst)2017 Drug cost: $430,463 (USD; Tot_Drug_Cst)2018 Drug cost: $309,072 (USD; Tot_Drug_Cst)2019 Drug cost: $664,758 (USD; Tot_Drug_Cst)2020 Drug cost: $1,667,444 (USD; Tot_Drug_Cst)2021 Drug cost: $1,814,163 (USD; Tot_Drug_Cst)2022 Drug cost: $1,917,901 (USD; Tot_Drug_Cst)2023 Drug cost: $1,253,971 (USD; Tot_Drug_Cst)2024 Drug cost: $1,631,482 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152378$25,594
201649213$190,922
201778418$430,463
201885381$309,072
201991483$664,758
2020132705$1,667,444
2021174855$1,814,163
2022179939$1,917,901
2023174757$1,253,971
2024203851$1,631,482

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.9K$7.8K2018 Medicare payment: $7,841 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,108 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R46$7,841
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R13$2,108
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more135266$95
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's131225$13
80053Blood test, comprehensive group of blood chemicals110256$10
36415Insertion of needle into vein for collection of blood sample136339$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count136420$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CabometyxCabozantinib S-Malate12360$291,053
PomalystPomalidomide13364$288,695
IbrancePalbociclib15420$229,433
RevlimidLenalidomide12336$204,706
LenalidomideLenalidomide12336$162,729

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$15,847AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Purvi Gada, MBBS?

Tedicare shows public-source Medicare data for Purvi Gada, MBBS (NPI 1639209224), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Purvi Gada, MBBS have ACO affiliation data?

Purvi Gada, MBBS is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483) and Essentia Health ACO, Inc. (MSSP, ACO ID A5617).

What billing organization is linked to Purvi Gada, MBBS?

Purvi Gada, MBBS is linked to MINNESOTA ONCOLOGY HEMATOLOGY, PA (billing NPI 1528035995) in the available physician profile data.

Does Purvi Gada, MBBS have Open Payments data?

Purvi Gada, MBBS has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.